Ergoteles’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-267,309
Closed -$11.3M 962
2023
Q2
$11.3M Buy
267,309
+227,767
+576% +$9.21M 0.54% 26
2023
Q1
$1.41M Buy
39,542
+12,620
+47% +$458K 0.06% 383
2022
Q4
$987K Sell
26,922
-22,605
-46% -$894K 0.04% 463
2022
Q3
$2.33M Buy
49,527
+32,495
+191% +$2.1M 0.08% 242
2022
Q2
$1.22M Buy
+17,032
New +$1.25M 0.04% 458
2022
Q1
Sell
-2,261
Closed -$232K 1731
2021
Q4
$232K Sell
2,261
-1,683
-43% -$162K 0.01% 961
2021
Q3
$345K Buy
+3,944
New +$357K 0.01% 737
2021
Q1
Sell
-95,300
Closed -$6.49M 1136
2020
Q4
$6.49M Buy
+95,300
New +$5.94M 0.22% 111

Other funds holding SYNH

Ergoteles's SYNH Position: Q3 2023 in Review

Ergoteles sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 267,309 shares — an estimated $11.3M sold.

Ergoteles first reported a position in SYNH in Q4 2020 and held it in 8 quarters. The position peaked at $11.3M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Ergoteles reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 267,309 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $11.3M.
  • Ergoteles first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2020 and held it in 8 quarters.
  • Ergoteles's Syneos Health, Inc. Class A Common Stock position peaked at $11.3M in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.